viernes, 6 de noviembre de 2026
BuscarExplore
Via News Knowledge File

NVIDIA Corporation

organization80% conf.·synced Nov 6, 2026

Technology company specializing in semiconductors and AI chips, IPO in 1999, Taiwan semiconductor dependency

60
sourced metrics
5481
relationships
20
stated objectives
8
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Stock Price
181.60USD
Nov 5, 2026reference only
Price 52 Week Low
165.17USD
Nov 5, 2026reference only
Stock Return Ytd
-3.8%
Nov 5, 2026reference only
Market Cap
4394720000000USD
Nov 5, 2026reference only
Price 52 Week High
239.24USD
Nov 5, 2026reference only
Shares Outstanding
24200000000.0shares
May 15, 2026reference only
Gross Profit
61157000000.0USD
Apr 26, 2026reference only
Stockholders Equity
195474000000.0USD
Apr 26, 2026reference only
Net Income
58321000000.0USD
Apr 26, 2026reference only
Total Liabilities
64000000000.0USD
Apr 26, 2026reference only
Operating Income
53536000000.0USD
Apr 26, 2026reference only
Rd Expense
6321000000.0USD
Apr 26, 2026reference only
Total Assets
259474000000.0USD
Apr 26, 2026reference only
Cost Of Revenue
20458000000.0USD
Apr 26, 2026reference only
Operating Cash Flow
50344000000.0USD
Apr 26, 2026reference only
Revenue
81615000000.0USD
Apr 26, 2026reference only
Cash
13237000000.0USD
Apr 26, 2026reference only
Eps
2.39USD_per_share
Apr 26, 2026reference only

Stated objectives

Regain billions of dollars in lost business through China market

source
target: billions stated

Share 15% or more of revenue from China sales with US government

source
target: 15 stated

Commission over 1 million square feet for manufacturing Blackwell chips in Arizona and AI supercomputers in Texas

source
target: 1 million square feet stated

Ramp up mass production of AI supercomputers in Texas by September 2026

source
by 2026-09-01 00:00:00stated

Q4 FY2026 revenue target

source
target: $65.0 billion, plus or minus 2% by 2026-01-25 00:00:00stated

Q4 FY2026 GAAP gross margin target

source
target: 74.8%, plus or minus 50 basis points by 2026-01-25 00:00:00stated

Q4 FY2026 non-GAAP gross margin target

source
target: 75.0%, plus or minus 50 basis points by 2026-01-25 00:00:00stated

Start shipping H200 chips to China

source
by 2026-02-01 00:00:00stated

Deliver up to 10x reduction in inference token cost compared to Blackwell platform

source
target: 10x stated

Reduce number of GPUs needed to train MoE models by 4x compared to Blackwell

source
target: 4x reduction stated

Relationship graph · 5481 connections

Developed by
1330
Supplies to
909
Competes with
729
Covered by
506
Customer of
424
Employs
320
Invested in
224
Partners with
176

Via News coverage

This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,996
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,996 hechos verificados con la fuente5,552 documentos fuente archivados
Consulta estos datos → isubstrate.com